title: Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer.
authors.affiliation: Clinical Pharmacology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.
authors.forename: W D
authors.initials: WD
authors.lastname: Figg
authors.forename: N
authors.initials: N
authors.lastname: Dawson
authors.forename: M N
authors.initials: MN
authors.lastname: Middleman
authors.forename: O
authors.initials: O
authors.lastname: Brawley
authors.forename: R M
authors.initials: RM
authors.lastname: Lush
authors.forename: A
authors.initials: A
authors.lastname: Senderowicz
authors.forename: S H
authors.initials: SH
authors.lastname: Steinberg
authors.forename: A
authors.initials: A
authors.lastname: Tompkins
authors.forename: E
authors.initials: E
authors.lastname: Reed
authors.forename: O
authors.initials: O
authors.lastname: Sartor
mesh_terms: D000368:Aged; D000616:Aminoglutethimide / Q000008:administration & dosage*; D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm; D005485:Flutamide / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D000616:Aminoglutethimide; D005485:Flutamide